Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V-2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia - a randomized, double-blind, placebo-controlled study

Abstract

Study evaluates the short-term effects of combination of satavaptan, a selective vasopresin V2 receptor antagonist, and diuretics on ascites in patients with liver cirrhosis and normonatraemia. The study was conducted as a randomized, double-blind, placebo-controlled study.

Keywords

• Satavaptan
• vasopresin
• diuretics
• ascites
• liver cirrhosis
• normonatraemia
• hyponatraemia